Bausch + Lomb Introduces Biotrue® ONEday For Astigmatism Contact Lenses
Valeant Pharmaceuticals International, Inc.’s (NYSE: VRX and TSX: VRX) (“Valeant” or the “Company”) wholly owned subsidiary Bausch + Lomb, a leading global eye health company, today announced the introduction of Biotrue® ONEday for Astigmatism daily disposable contact lenses. Approximately 73.2 million people in the U.S. are astigmatic, but only 8.8...